Back to search

Article

Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment Response

2020-12-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>N6-methyladenosine (m6A) modification plays an essential role in diverse key biological processes and may take part in the development and progression of hepatocellular carcinoma (HCC). Here, we systematically analyzed expression profiles and prognostic values of 13 widely reported m6A modification related genes in HCC.<bold>Methods</bold>: mRNA expression of 13...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99937bf3-206e-50ed-a786-c1940111215d
DOI
10.21203/rs.3.rs-130710/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment ResponseDOI 10.21203/rs.3.rs-130710/v1
Select a neighboring publication to make it the new centre.